ES402720A1 - Metodo mejorado para determinar la presencia de compuestos biologicamente activos empleando una enzima modificada. - Google Patents

Metodo mejorado para determinar la presencia de compuestos biologicamente activos empleando una enzima modificada.

Info

Publication number
ES402720A1
ES402720A1 ES402720A ES402720A ES402720A1 ES 402720 A1 ES402720 A1 ES 402720A1 ES 402720 A ES402720 A ES 402720A ES 402720 A ES402720 A ES 402720A ES 402720 A1 ES402720 A1 ES 402720A1
Authority
ES
Spain
Prior art keywords
enzyme
ligand
linked
aplification
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES402720A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syva Co
Original Assignee
Syva Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syva Co filed Critical Syva Co
Publication of ES402720A1 publication Critical patent/ES402720A1/es
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/946—CNS-stimulants, e.g. cocaine, amphetamines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES402720A 1971-05-14 1972-05-13 Metodo mejorado para determinar la presencia de compuestos biologicamente activos empleando una enzima modificada. Expired ES402720A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14360971A 1971-05-14 1971-05-14

Publications (1)

Publication Number Publication Date
ES402720A1 true ES402720A1 (es) 1976-12-01

Family

ID=22504809

Family Applications (1)

Application Number Title Priority Date Filing Date
ES402720A Expired ES402720A1 (es) 1971-05-14 1972-05-13 Metodo mejorado para determinar la presencia de compuestos biologicamente activos empleando una enzima modificada.

Country Status (12)

Country Link
JP (1) JPS5327763B1 (it)
BR (1) BR7202989D0 (it)
CA (1) CA1003770A (it)
CH (1) CH553410A (it)
DE (1) DE2223385C3 (it)
ES (1) ES402720A1 (it)
FR (1) FR2139505A5 (it)
GB (2) GB1401298A (it)
IL (1) IL39323A (it)
IT (1) IT972332B (it)
NL (1) NL170564C (it)
SE (1) SE403190B (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1028643A (en) * 1975-02-20 1978-03-28 Judith I. Blakemore Polylodothyronine immunoassay
US4104367A (en) * 1976-10-13 1978-08-01 Hoffmann-La Roche Inc. Radioimmunoassay for methadone
US4220450A (en) * 1978-04-05 1980-09-02 Syva Company Chemically induced fluorescence immunoassay
DE2923139A1 (de) * 1979-06-07 1980-12-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von immunologisch aktiven enzymmarkierten konjugaten
WO1981001414A1 (en) * 1979-11-19 1981-05-28 Charles Hospital Dev An improved method of non homogenous enzyme immunoassay
EP0095286B1 (en) * 1982-05-26 1985-12-18 Boots-Celltech Diagnostics Limited Immunoassay
GB8407736D0 (en) * 1984-03-26 1984-05-02 Univ London Detecting specific polynucleotide sequences
IT1178788B (it) * 1984-12-21 1987-09-16 Sclavo Spa Metodo immunoenzimatico per la determinazione di analiti e composizione adatti allo scopo
US4833073A (en) * 1987-01-27 1989-05-23 Hoffmann-La Roche Inc. Immunoassay for tetrahydrocannabinol metabolites
US5137804A (en) * 1988-05-10 1992-08-11 E. I. Du Pont De Nemours And Company Assay device and immunoassay
US5374524A (en) * 1988-05-10 1994-12-20 E. I. Du Pont De Nemours And Company Solution sandwich hybridization, capture and detection of amplified nucleic acids
US5196306A (en) * 1989-03-29 1993-03-23 E. I. Du Pont De Nemours And Company Method for the detection or quantitation of an analyte using an analyte dependent enzyme activation system
EP2418492B1 (en) * 2010-08-10 2018-10-10 Randox Laboratories Ltd. Immunoreagent for meprobamate

Also Published As

Publication number Publication date
IT972332B (it) 1974-05-20
GB1401297A (en) 1975-07-16
SE403190B (sv) 1978-07-31
NL170564B (nl) 1982-06-16
DE2223385B2 (de) 1979-02-22
DE2223385A1 (de) 1973-01-04
FR2139505A5 (it) 1973-01-05
IL39323A (en) 1975-08-31
CA1003770A (en) 1977-01-18
JPS5327763B1 (it) 1978-08-10
IL39323A0 (en) 1972-06-28
NL170564C (nl) 1982-11-16
NL7206434A (it) 1972-11-16
BR7202989D0 (pt) 1973-11-01
GB1401298A (en) 1975-07-16
CH553410A (fr) 1974-08-30
DE2223385C3 (de) 1984-10-25

Similar Documents

Publication Publication Date Title
ES414618A1 (es) Procedimiento mejorado para la deteccion y determinacion de haptenos.
ES402720A1 (es) Metodo mejorado para determinar la presencia de compuestos biologicamente activos empleando una enzima modificada.
ES452916A1 (es) Procedimiento para determinar la actividad de creantincina- sa-mb en una muestra de liquido corporal.
GB1340366A (en) Fluid analysis apparatus
ES398372A1 (es) Procedimiento para la deteccion y determinacion de un com- ponente de la reaccion entre una proteina de fijacion espe- cifica y la sustancia fijable correspondiente.
ES452054A1 (es) Metodo para el estudio de reacciones enzimaticas y otras reacciones bioquimicas.
FI51744C (fi) Menetelmä ja koereagenssiyhdistelmä triglyseridien osoittamiseksi ents ymaattisesti ja kvantitatiivisesti.
ES467831A1 (es) Procedimiento para la preparacion de un reactivo para deter-minar un material inmunologicamente activo
ATE158344T1 (de) Verfahren zum nachweis der differenzierung und der invasivität von karzinomzellen
GB1540728A (en) Polyiodothyronine immunoassay
ES309450A1 (es) Metodo de prueba de diagnostico para determinar la funcion ovulatoria.
ES418690A1 (es) Procedimiento para la preparacion de di-metionil-di-metio- nina.
BE785179A (fr) Reactif enzymatique pour la determination et le dosage des hydroxysteroides
NL179658B (nl) Werkwijze voor het bepalen van de enzymactiviteit van desoxyribonuclease, desoxyribonuclease-antilichamen respectievelijk desoxyribonuclease-b-antilichamen.
SU510168A3 (ru) Способ количественного опреде-лени веществ,способных к фермен-тативному окислению в водномрастворе
ES408273A1 (es) Procedimiento para la preparacion de 4-cloro-2,5-dimetoxi-anilina.
ES401014A1 (es) Metodo mejorado para la determinacion enzimatica del conte-nido de etanol de un material que contiene etanol.
ES185888U (es) Un portaobjetos de ensayo.
ES328267A1 (es) Procedimiento para la determinacion de la presencia de filtrado de sondeo en una muestra de pozo.
ES294807A1 (es) Dispositivo para el estudio de los caracteres fermentativos de las células vivas
SU482659A1 (ru) Способ определени концентрации сажи
ES455975A1 (es) Un procedimiento de obtencion de una disolucion enriquecida en uroquinasa.
ES387905A1 (es) Un procedimiento para la conversion de un hidrocarburo.
SU445361A1 (ru) Способ эмиссионного инфракрасного количественного анализа примесей
DK143578C (da) Roerformig sonde til bestemmelse af hydrogenionaktiviteten i biologiske medier